ASPIRA PATHLAB & DIAGNOSTICS | ASTER DM HEALTHCARE | ASPIRA PATHLAB & DIAGNOSTICS / ASTER DM HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.6 | 42.3 | - | View Chart |
P/BV | x | 2.6 | 4.0 | 64.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
ASPIRA PATHLAB & DIAGNOSTICS ASTER DM HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
ASTER DM HEALTHCARE Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / ASTER DM HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 275 | 27.2% | |
Low | Rs | 26 | 163 | 15.8% | |
Sales per share (Unadj.) | Rs | 14.0 | 238.9 | 5.9% | |
Earnings per share (Unadj.) | Rs | -0.1 | 9.5 | -0.9% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 25.1 | 5.8% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 12.4 | 89.0 | 13.9% | |
Shares outstanding (eoy) | m | 10.29 | 499.51 | 2.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 0.9 | 390.8% | |
Avg P/E ratio | x | -583.7 | 23.0 | -2,536.3% | |
P/CF ratio (eoy) | x | 34.6 | 8.7 | 397.2% | |
Price / Book Value ratio | x | 4.1 | 2.5 | 165.2% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 518 | 109,418 | 0.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 39,652 | 0.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 119,329 | 0.1% | |
Other income | Rs m | 3 | 783 | 0.4% | |
Total revenues | Rs m | 148 | 120,111 | 0.1% | |
Gross profit | Rs m | 16 | 16,269 | 0.1% | |
Depreciation | Rs m | 16 | 7,804 | 0.2% | |
Interest | Rs m | 4 | 3,897 | 0.1% | |
Profit before tax | Rs m | -1 | 5,351 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 596 | 0.0% | |
Profit after tax | Rs m | -1 | 4,755 | -0.0% | |
Gross profit margin | % | 11.0 | 13.6 | 80.8% | |
Effective tax rate | % | 0 | 11.1 | -0.0% | |
Net profit margin | % | -0.6 | 4.0 | -15.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 49,216 | 0.1% | |
Current liabilities | Rs m | 16 | 46,553 | 0.0% | |
Net working cap to sales | % | 29.5 | 2.2 | 1,324.1% | |
Current ratio | x | 3.7 | 1.1 | 349.5% | |
Inventory Days | Days | 88 | 18 | 483.1% | |
Debtors Days | Days | 590 | 7 | 8,261.4% | |
Net fixed assets | Rs m | 115 | 99,141 | 0.1% | |
Share capital | Rs m | 103 | 4,995 | 2.1% | |
"Free" reserves | Rs m | 25 | 39,486 | 0.1% | |
Net worth | Rs m | 128 | 44,481 | 0.3% | |
Long term debt | Rs m | 10 | 13,123 | 0.1% | |
Total assets | Rs m | 173 | 148,356 | 0.1% | |
Interest coverage | x | 0.8 | 2.4 | 33.2% | |
Debt to equity ratio | x | 0.1 | 0.3 | 25.6% | |
Sales to assets ratio | x | 0.8 | 0.8 | 103.6% | |
Return on assets | % | 1.9 | 5.8 | 32.5% | |
Return on equity | % | -0.7 | 10.7 | -6.5% | |
Return on capital | % | 2.4 | 16.1 | 14.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 622 | 0.0% | |
Fx outflow | Rs m | 0 | 145 | 0.0% | |
Net fx | Rs m | 0 | 477 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 18,340 | -0.0% | |
From Investments | Rs m | 2 | -9,719 | -0.0% | |
From Financial Activity | Rs m | -9 | -8,174 | 0.1% | |
Net Cashflow | Rs m | -8 | 657 | -1.2% |
Indian Promoters | % | 18.7 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 41.9 | - | |
Indian inst/Mut Fund | % | 0.0 | 47.2 | - | |
FIIs | % | 0.0 | 33.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 58.1 | 139.8% | |
Shareholders | 1,512 | 80,931 | 1.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS NARAYANA HRUDAYALAYA METROPOLIS HEALTHCARE KIMS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | ASTER DM HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.27% | -1.25% | 0.01% |
1-Month | -2.29% | 12.83% | -0.08% |
1-Year | -3.03% | 86.27% | 53.79% |
3-Year CAGR | 2.29% | 46.84% | 14.92% |
5-Year CAGR | -1.66% | 25.58% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the ASTER DM HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of ASTER DM HEALTHCARE the stake stands at 41.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of ASTER DM HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
ASTER DM HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of ASTER DM HEALTHCARE.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.